Methyl 2-methyl-2-phenylpropanoate | CAS:57625-74-8

We serve Methyl 2-methyl-2-phenylpropanoate CAS:57625-74-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyl 2-methyl-2-phenylpropanoate

Chemical Name:   Methyl 2-methyl-2-phenylpropanoate
CAS.NO:57625-74-8
Synonyms:
Methyl Dimethylbenzeneacetate

Molecular Formula: C11H14O2
Molecular Weight:178.22800

Physical and Chemical Properties:
Density: 1.012g / cm3
Boiling point: 230.2ºC at 760 mmHg
Melting point: /
Flash point: 92.2ºC
Refractive index: 1.491

Specification:
Appearance: Colorless and transparent liquid
Purity:≥98%
Moisture Content: ≤0.1%
Impurity: ≤0.2%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Fexofenadine hydrochloride CAS:138452-21-8
Intermediates of Fexofenadine CAS:83799-24-0



Contact us for information like Methyl 2-methyl-2-phenylpropanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl Dimethylbenzeneacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 2-methyl-2-phenylpropanoate Use and application,Methyl 2-methyl-2-phenylpropanoate technical grade,usp/ep/jp grade.


Related News: High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.2-Fluoro-3-Chloro-5-Bromopyridine manufacturer Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.3,5-Difluoroaniline supplier Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain.2,5-DICHLOROFLUOROBENZENE vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.